JERSEY, Channel Islands,
May 19, 2014 /PRNewswire/
-- Quotient Limited ("Quotient"; NASDAQ: QTNTU), a
commercial-stage diagnostics company, today announced that
Paul Cowan, Chairman and Chief
Executive Officer, will present at the UBS Global Healthcare
Conference on Tuesday, May 20 at
10:00 a.m. Eastern Time.
About Quotient Limited
Quotient is an established, commercial-stage diagnostics company
committed to reducing healthcare costs and improving patient care
through the development and commercialization of innovative tests,
currently focused on blood grouping and serological disease
screening. Quotient is developing its proprietary MosaiQ™
technology platform to offer a breadth of tests that is unmatched
by any commercially available transfusion diagnostic instrument
platform. The company's operations are based in Edinburgh, Scotland; Newtown, Pennsylvania; and Eysins,
Switzerland.
Forward-Looking Statements
This news release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include statements regarding our expectations of
continued growth, the development, regulatory approval,
commercialization and impact of MosaiQ and other new products and
current estimates of fiscal 2015 operating results. Such
statements are based on current assumptions that involve risks and
uncertainties that could cause actual outcomes and results to
differ materially. These risks and uncertainties, many of which are
beyond our control, include delays or denials of regulatory
approvals or clearances for products or applications; market
acceptance of our products; the impact of competition; the impact
of facility expansions and expanded product development,
clinical, sales and marketing activities on operating expenses;
delays or other unforeseen problems with respect to manufacturing,
product development or field trial studies; adverse results in
connection with any ongoing or future legal proceeding; continued
or worsening adverse conditions in the general domestic and global
economic markets; as well as the other risks set forth in the
company's filings with the Securities and Exchange Commission.
Investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof.
Quotient disclaims any obligation to update these forward-looking
statements.
The Quotient logo and MosaiQ™ are registered trademarks or
trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
SOURCE Quotient Limited